Description |
homeobox C4 |
ring finger and CHY zinc finger domain containing 1 |
Image |
No pdb structure |
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Coronary artery disease ( 32469254)
- Diastolic blood pressure ( 27841878)
- Diastolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
- Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) ( 29912962)
- Mean arterial pressure x alcohol consumption interaction (2df test) ( 29912962)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Medication use (calcium channel blockers) ( 31015401)
- Pulse pressure ( 27841878 30578418)
- Pulse pressure x alcohol consumption interaction (2df test) ( 29912962)
- Response to fenofibrate (LDL cholesterol levels) ( 27002377)
- Systolic blood pressure ( 27841878 27618447 30578418)
- Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) ( 29912962)
- Systolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
- Triglyceride levels ( 32203549)
- Waist circumference ( 28552196)
- Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) ( 28448500)
- Waist circumference adjusted for BMI in active individuals ( 28448500)
- Waist circumference adjusted for body mass index ( 28552196 28448500)
- Waist-to-hip ratio adjusted for BMI ( 26426971)
- Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) ( 28443625)
- Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625)
- Waist-to-hip ratio adjusted for BMI in non-smokers ( 28443625)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
- Waist-to-hip ratio adjusted for body mass index ( 25673412)
|
- Metabolite levels ( 23823483)
- Response to tocilizumab in rheumatoid arthritis ( 22491018)
|
Interacting Genes |
17 interacting genes:
APP
CLK3
CSNK2A1
ELMOD2
EXOSC5
HTT
NCK2
NSD3
PRKDC
PRMT5
PRMT6
RCHY1
RNF32
RPRD1B
SOX10
SUV39H1
XRCC6
|
75 interacting genes:
ADAMTSL4
AIG1
ANGPTL8
AOX1
AR
ARF4
ATN1
BIRC3
CAMK2A
CAMK2G
CDK9
CDKN1B
CHD8
CHEK2
COPE
COX6C
CREB5
CYBA
DAPK1
DCUN1D5
F7
FADS6
GFI1B
GORAB
HOXA1
HOXA2
HOXA3
HOXB1
HOXB2
HOXB5
HOXC11
HOXC4
HOXD10
HRG
KAT5
KLHL41
KRTAP9-2
LIMS2
MDM2
MEOX2
MSH3
MT2A
NKD2
NLK
NOTCH2NLA
PGLS
PLAGL2
PMM1
PRDX4
RAB11A
RBM38
RILP
RPLP1
RPN2
SEMA4C
SERPINA1
SERPINA5
SERTAD1
SRPRB
TAOK2
TMBIM1
TMEM14C
TMEM184A
TP53
TP63
TP73
TRIM8
UBASH3B
UBC
UBE2D1
UBE2D2
UBE2D3
UBE2D4
WDR74
ZNF160
|
Entrez ID |
3221 |
25898 |
HPRD ID |
00860 |
07607 |
Ensembl ID |
ENSG00000198353
|
ENSG00000163743
|
Uniprot IDs |
A0A024RB51
P09017
Q86TF7
|
Q96PM5
|
PDB IDs |
|
2JRJ
2K2C
2K2D
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|